Commentary|Podcasts|February 17, 2026

Pharma Pulse: Restoring Physician Focus

In today’s Pharma Pulse, the Senate tackles the regulatory red tape driving physician burnout, while Edwards Lifesciences ends its anti-copycat policy to settle European Commission antitrust concerns.

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

  • In a recent Senate hearing titled "The Doctor Is Out: How Washington’s Rules Drove Physicians Out of Medicine," experts warned that excessive regulatory and administrative burdens—from prior authorizations to "computer-generated rubbish" in referrals—are the primary drivers of physician burnout. With more than half of practices reporting the loss of at least one doctor to burnout in the last three years, lawmakers are now eyeing the Improving Seniors Timely Access to Care Act to slash the red tape that often leaves patients waiting for critical treatments.
  • Meanwhile, Edwards Lifesciences has officially withdrawn its global "anti-copycat" policy. The move prompted the European Commission to close its investigation into whether the medical device giant was unfairly restricting competition by cutting off support to doctors and researchers who collaborated with competitors.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on AudioboomSpotify, or iHeart.